Metabolic Surgery Beats Medical, Lifestyle Interventions for T2D Remission
Additional benefits from surgery seen for diabetes-related comorbidities and weight loss
Type 2 Diabetes
Cases of Youth-Onset Type 2 Diabetes Climbed During Pandemic
Substantial increase in new cases seen during first year of pandemic
Dapagliflozin Linked to Consistent Reductions in CV and Kidney Outcomes in T2D
A study was conducted to determine the efficacy and safety of dapagliflozin when taken with CV medications in patients with type 2 diabetes and HF, kidney disease, or both.
Abdominal CT Biomarkers May Predict Type 2 Diabetes
Use of deep learning may identify abdominal computed tomography (CT) biomarkers that can help diagnose type 2 diabetes mellitus at an earlier stage.
Nonmedical Interventions May Improve Type 2 Diabetes Outcomes
Addressing the social determinants of health may improve diabetes outcomes.
Dronedarone Reduces CV Hospitalization, Death in Patients With AF With, Without T2D
Researchers sought to assess the safety and efficacy of dronedarone therapy for patients with atrial fibrillation and diabetes.
Canagliflozin Use in Patients With PAD Linked to Reduced Risk for CV, Renal Outcomes
Investigators examined the effect of canagliflozin in patients with both type 2 diabetes and peripheral artery disease.
Maintaining Weight Loss After Intensive Lifestyle Intervention and Lower CV Risk in Type 2 DM
Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level.
Type 2 Diabetes Tied to Accelerated Brain Aging, Cognitive Decline
Type 2 diabetes mellitus (T2DM) is associated with neurocognitive changes suggestive of accelerated brain aging.
- Loading...
Loading...
Next post in Metabolic
Loading... 
Loading...